Correlogic, FDA To Discuss Status Of OvaCheck Ovarian Cancer Test
FDA is requesting a meeting with Correlogic Systems to clarify the regulatory path to market for the OvaCheck early-stage ovarian cancer test
FDA is requesting a meeting with Correlogic Systems to clarify the regulatory path to market for the OvaCheck early-stage ovarian cancer test